Jens Erik Knudsen - Jun 27, 2022 Form 4 Insider Report for Allarity Therapeutics, Inc. (ALLR)

Signature
/s/ Jens Erik Knudsen
Stock symbol
ALLR
Transactions as of
Jun 27, 2022
Transactions value $
$0
Form type
4
Date filed
7/14/2022, 07:26 PM
Previous filing
Dec 22, 2021

Jens Erik Knudsen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

This "Exit" Form 4 is being voluntarily filed to report solely that the Reporting Person is no longer serving in the role as the Company's Chief Financial Officer effective as of June 27, 2022.